Position in HLN
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$968,727
-$10,547 QoQ
Shares Held
96,776
-0.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Calamos Advisors LLC holds $8,272,786 across 2 Drug Manufacturers - Specialty & Generic names.
All Filings in HLN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $968,727 | 96,776 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $979,274 | 96,862 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $879,643 | 98,065 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $1,016,934 | 98,065 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $1,008,800 | 98,037 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $931,571 | 97,649 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $1,033,126 | 97,649 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $806,580 | 97,649 | Shares | Sole | 2024-07-25 | |
| No filing history on record for this holder in this stock. | ||||||